ClinicalTrials.gov
public full text
Public Domain
The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers
This study will investigate changes in insulin resistance, lipid metabolism and endocrine profile in HIV-negative subjects exposed to dolutegravir (an antiretroviral drug used in HIV treatment) in order to investigate the role all these different factors may potentially have in weight gain recently reported in clinical cohorts.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Avexitide for Treatment of Post-Bariatric Hypoglycemia#850134
- Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics#1261244
- Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women#1362911
- Exploratory longitudinal study of serum adipokines and lipid profile in breast cancer patients receiving adjuvant chemotherapy#310592
- Impact of Antiretroviral Therapy on Cardiac Biomarkers#1230137
Record · ID 1186005
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive